Financial Engines Advisors L.L.C. Vaxart, Inc. Transaction History

Financial Engines Advisors L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.57 - $0.85 $5,699 - $8,500	10,000 New	10,000 $5,000
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.41 $6,000 - $14,100	10,000 New	10,000 $7,000
Q1 2022 May 12, 2022	BUY	$4.29 - $6.64 $42,900 - $66,400	10,000 New	10,000 $50,000
Q4 2021 Feb 10, 2022	SELL	$5.77 - $7.96 $86,550 - $119,400	-15,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.67 - $9.8 $100,050 - $147,000	15,000 New	15,000 $119,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.